All In Biotech

Free tool

FAERS Monitor: Glucagon

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 201849 or its brand name (Glucagon, Glucagon Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

3,600

Serious

2,995

83% of reports

Hospitalization

1,923

Death reported

635

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea362
  • drug ineffective332
  • acute kidney injury323
  • hypotension298
  • condition aggravated257
  • toxicity to various agents237
  • haemoptysis224
  • anxiety221
  • hypoglycaemia207
  • pain in extremity207
  • asthma196
  • off label use193
  • nausea186
  • vomiting185
  • lung disorder184

Reports by year received

View as table
YearReports
200419
200524
200620
200726
200823
200949
201034
201153
201253
201354
201483
2015230
2016202
2017210
2018207
2019305
2020353
2021316
2022226
2023303
2024297
2025306
2026207

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,559 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
haemoptysisSignal22447.341.610,038
hypoglycaemiaSignal20725.021.94,744
lung disorderSignal18422.019.13,665
acute kidney injurySignal32312.411.13,377
asthmaSignal19610.18.91,613
hypotensionSignal2988.77.82,037
toxicity to various agentsSignal2378.27.31,506
condition aggravatedSignal2574.94.4815
anxietySignal2214.54.0614
pain in extremitySignal2074.13.6490
dyspnoeaSignal3623.73.4743
vomitingSignal1852.32.0138
drug ineffective3321.51.353
nausea1861.41.219
off label use1931.31.113

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.